Doctors Were Chastised For Wellbutrin Claims: GSK Exec

Law360, District of Columbia (May 5, 2011, 6:14 PM EDT) -- GlaxoSmithKline PLC worked with physicians to stop promotion of antidepressant Wellbutrin for off-label uses, a company executive testified Thursday in the Maryland trial of a former GSK attorney who allegedly obstructed a probe into the drug's marketing.

GSK became aware in 2002 that the company's two top promotional-speaker doctors were using slides in their presentations including information for off-label uses of the drug, but swiftly took steps to bring the pair into compliance with all regulations, GSK executive James Millar said in the trial of the...
To view the full article, register now.